Target Health Resources

The High Cost and Questionable Impact of 100% SDV

February 1, 2011

,
Data Services

|

Article

It is rare for the clinical trials industry to spend time and money on a tedious and labor intensive process when it is not required by the U.S. Food and Drug Administration (FDA). But that’s exactly what is happening with source data verification.

Download Now
The CenterWatch Monthly
CenterWatch
February 1, 2011
https://www.centerwatch.com/

Contact Target Health

Reach out today and let us know how we can help you!
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form